Dr. Jay Raman, MD
Claim this profilePenn State Health Milton S. Hershey Medical Center and College of Medicine
Studies Transitional Cell Carcinoma
Studies Bladder Cancer
5 reported clinical trials
6 drugs studied
Area of expertise
1Transitional Cell Carcinoma
Stage II
Stage I
2Bladder Cancer
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Jay Raman, MD is currently running
Padeliporfin VTP
for Bladder Cancer
This is a phase 3, open label, single arm study of padeliporfin in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade non-invasive upper tract urothelial carcinoma in either the kidney or the ureter. Patients will be treated with padeliporfin VTP in two phases: an Induction Treatment Phase and a Maintenance Treatment Phase and will be followed up for up to an additional 48 months in the long term (non intervention) follow up phase with the specific duration depending on the patient's response to treatment
Recruiting2 awards Phase 314 criteria
UGN-301
for Bladder Cancer
This trial tests UGN-301, a drug delivered directly into the bladder, alone or with other drugs. It targets patients with a specific type of recurrent bladder cancer. The goal is to find the safest and most effective dose by adjusting based on early findings.
Recruiting1 award Phase 16 criteria
More about Jay Raman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jay Raman, MD has experience with
- UGN-102
- TURBT
- Zalifrelimab (UGN-301)
- Padeliporfin VTP
- Ambu® AScope™ 4 Cysto With The AView™ 2 Advance
- Standard Of Care Reusable Cystoscope
Breakdown of trials Jay Raman, MD has run
Transitional Cell Carcinoma
Bladder Cancer
Cancer
Recurrence
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jay Raman, MD specialize in?
Jay Raman, MD focuses on Transitional Cell Carcinoma and Bladder Cancer. In particular, much of their work with Transitional Cell Carcinoma has involved Stage II patients, or patients who are Stage I.
Is Jay Raman, MD currently recruiting for clinical trials?
Yes, Jay Raman, MD is currently recruiting for 2 clinical trials in Hershey Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Jay Raman, MD has studied deeply?
Yes, Jay Raman, MD has studied treatments such as UGN-102, TURBT, Zalifrelimab (UGN-301).
What is the best way to schedule an appointment with Jay Raman, MD?
Apply for one of the trials that Jay Raman, MD is conducting.
What is the office address of Jay Raman, MD?
The office of Jay Raman, MD is located at: Penn State Health Milton S. Hershey Medical Center and College of Medicine, Hershey, Pennsylvania 17033 United States. This is the address for their practice at the Penn State Health Milton S. Hershey Medical Center and College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.